2023
DOI: 10.1530/endoabs.90.ep599
|View full text |Cite
|
Sign up to set email alerts
|

Treatment with 177Lu-dotatate in metastasic advanced neuroendocrine tumors with positive expression of somatostatin receptors, in a third level hospital in Spain from 2015-2022

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles